We are live on ! Find out more
ACIU icon

AC Immune
ACIU

35 hedge funds and large institutions have $49.8M invested in AC Immune in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 12 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

3% less funds holding

Funds holding: 36 → 35 (-1)

3.15% less ownership

Funds ownership: 19.67% → 16.52% (-3.2%)

11% less call options, than puts

Call options by funds: $105K | Put options by funds: $118K

13% less capital invested

Capital invested by funds: $57.2M → $49.8M (-$7.35M)

50% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 12

Holders
35
Holders Change
-1
Holders Change %
-2.78%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
6
Reduced
12
Closed
5
Calls
$105K
Puts
$118K
Net Calls
-$13K
Net Calls Change
-$516K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$294K
2
Wells Fargo
Wells Fargo
California
+$172K
3
UBS Group
UBS Group
Switzerland
+$123K
4
Renaissance Technologies
Renaissance Technologies
New York
+$75.6K
5
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$9.81K

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$1.94M
2
AWCI
Alpine Woods Capital Investors
New York
-$200K
3
VEA
Virtus ETF Advisers
New York
-$124K
4
Morgan Stanley
Morgan Stanley
New York
-$121K
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$95K
Name Holding Trade Value Shares
Change 		Change in
Stake
BI
1
BVF Inc
California
$26.8M – – –
Morgan Stanley
2
Morgan Stanley
New York
$7.11M -$121K -35,288 -2%
PIM
3
Platinum Investment Management
Australia
$3.83M -$10.3K -3,000 -0.3%
AG
4
Artal Group
Luxembourg
$3.61M – – –
Wells Fargo
5
Wells Fargo
California
$1.96M +$172K +50,408 +10%
Renaissance Technologies
6
Renaissance Technologies
New York
$1.71M +$75.6K +22,100 +5%
BlackRock
7
BlackRock
New York
$1.37M +$294K +85,959 +29%
Deutsche Bank
8
Deutsche Bank
Germany
$1.02M – – –
Assenagon Asset Management
9
Assenagon Asset Management
Luxembourg
$532K – – –
EP
10
Eversept Partners
New York
$450K – – –
Handelsbanken Fonder
11
Handelsbanken Fonder
Sweden
$365K – – –
State Street
12
State Street
Massachusetts
$210K -$1.73K -507 -0.9%
UBS Group
13
UBS Group
Switzerland
$198K +$123K +36,000 +191%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$133K – – –
Goldman Sachs
15
Goldman Sachs
New York
$104K +$257 +75 +0.3%
BCV
16
Banque Cantonale Vaudoise
Switzerland
$80K +$2.29K +670 +3%
KCIA
17
Kingsbury Capital Investment Advisors
Illinois
$68K -$366 -107 -0.6%
Susquehanna International Group
18
Susquehanna International Group
Pennsylvania
$60K -$32.7K -9,562 -37%
LBC
19
Lawrence B. Cohen
$46K – – –
Dimensional Fund Advisors
20
Dimensional Fund Advisors
Texas
$45K – – –
CLOS
21
Compagnie Lombard Odier SCmA
Switzerland
$36K – – –
Royal Bank of Canada
22
Royal Bank of Canada
Ontario, Canada
$17K -$7.53K -2,200 -32%
JP Morgan Chase
23
JP Morgan Chase
New York
$13K -$20.2K -5,918 -63%
Osaic Holdings
24
Osaic Holdings
Arizona
$11K -$342 -100 -3%
BNP Paribas Financial Markets
25
BNP Paribas Financial Markets
France
$10.4K +$9.81K +2,869 New
1
2

ACIU Hedge Fund Activity: Q2 2022 in Review

35 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q2 2022, worth a combined $49.8M — down 13% from $57.2M a quarter earlier.

Fund positioning in ACIU was balanced in Q2 2022: 5 funds opened new positions, 5 closed out, 6 added to existing stakes and 12 trimmed.

The largest buyer was BlackRock, adding an estimated $294K. The largest seller was EcoR1 Capital, exiting entirely with an estimated $1.94M sold.

  • 35 institutional investors held AC Immune (ACIU) as of Q2 2022, down from 36 in Q1 2022.
  • Funds reported $49.8M of AC Immune stock for Q2 2022, down 13% quarter-over-quarter.
  • 5 funds opened new AC Immune positions in Q2 2022 and 5 closed out, a net change of 0 holders.
  • The largest AC Immune buyer in Q2 2022 was BlackRock, an estimated $294K added.
  • The largest AC Immune seller in Q2 2022 was EcoR1 Capital, an estimated $1.94M sold.

Based on aggregated 13F filings for Q2 2022.